Hepatica transsilvanica
Hepatica transsilvanica · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Hepatica transsilvanica is a perennial herbaceous plant that has garnered significant interest within the field of pharmacological research. Recent scientific investigations have focused on the biological potential of its various chemical constituents. Specifically, researchers have explored the therapeutic efficacy of the plant's extract in controlled laboratory settings. Studies indicate that this preparation exhibits notable antiproliferative activities against certain cell lines. Consequently, this species represents a promising subject for the development of future medicinal compounds.
- Synonyms
- Anemone Transsilvanica · Anemone Hepatica Var. Transylvanica · 1 more
- Common names
- Not available
- Family
- Ranunculaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Common Names
Hepatica transsilvanica is a distinctive woodland perennial known by a variety of descriptive common names across different languages. In Romanian, it is affectionately referred to as Crucea voinicului, while the Hungarian name erdélyi májvirág highlights its regional identity. The plant is also widely recognized in German-speaking regions as Siebenbürger Leberblümchen, including the specific variation Siebenbürger Leberblümchen (DE). Furthermore, it carries the name Ungarsk Anemone, reflecting its botanical connections. These diverse titles underscore the rich cultural and linguistic heritage associated with this beautiful species.
Sources: Catalogue of Life (COL)
Synonyms
Hepatica transsilvanica is a botanical species that is frequently identified through various taxonomic synonyms. In many scientific records, you may encounter it referred to as Anemone hepatica var. transylvanica. It is also commonly documented under the name Anemone transsilvanica in older literature. Furthermore, the plant is sometimes classified as Hepatica multiloba depending on the specific botanical framework being used. Understanding these overlapping names is essential for accurate identification and research within the field of botany.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Hepatica transsilvanica belongs to the expansive kingdom Plantae, marking its place among the diverse world of vegetation. Within this vast group, the species is classified under the class Equisetopsida. It further resides in the order Ranunculales, a lineage that defines much of its biological structure. As a member of the Ranunculaceae family, it shares common traits with many other delicate wildflowers. Ultimately, this plant is a distinct representative of the genus Hepatica.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Ranunculaceae |
| Genus | Hepatica |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Hepatica transsilvanica is a notable plant species with a distribution that spans across much of Europe. It is commonly found throughout Middle Europe, including significant populations within Germany. The species also maintains a strong presence in Southeastern Europe, where it thrives in diverse habitats. Specifically, Romania serves as a key region for its natural occurrence and growth. This wide geographic range highlights the plant's adaptability to various European landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Hepatica transsilvanica belongs to a group of Ranunculaceae species that have long been utilized in traditional folk medicine to address various pathologies. Recent scientific investigations have sought to validate these traditional uses by assessing the pharmacological properties of several ethanolic extracts. Among the findings, specific species have demonstrated significant biological potential, including notable antiproliferative activity. This capacity to inhibit cell growth suggests that these plants could serve as valuable precursors for pharmaceutical development. Consequently, these extracts represent promising candidates for the creation of novel plant-based antioxidant and antiproliferative compounds.
Compounds
Conditions
Hepatica transsilvanica exhibits significant antiproliferative activity against both Caco-2 and HT29 cell lines. According to the research, the extract demonstrates its effectiveness through a 3-(4,5-dimethylthiazol-2-yl), 2,5-diphenyltetrazolium bromide (MTT) assay. Specifically, the plant shows a half-maximal inhibitory concentration of 46.9 μg/mL against Caco-2 cells. Furthermore, it achieves an IC50 of 70.2 μg/mL when treating the HT29 cell line. These results highlight the potential of the species to serve as a candidate for novel antiproliferative compounds.
Preparations
Hepatica transsilvanica is prepared as an extract within the context of studying medicinal Ranunculaceae species. This specific preparation method allows researchers to evaluate the pharmacological potential of the plant. By utilizing an extract, scientists can test the substance for antioxidant, antiproliferative, and antiparasitic properties. Such processing is a standard approach for investigating the bioactive components of traditional medicinal plants. Consequently, the extract serves as a critical tool for identifying potential candidates for novel plant-based compounds.